Get my own profile
Public access
View all2 articles
3 articles
available
not available
Based on funding mandates
Co-authors
- Laura A. Sordillo, MS, MPhil, PhDInstitute for Ultrafast Spectroscopy and Lasers, Dept. of PhysicsVerified email at ccny.cuny.edu
- Robert R. AlfanoThe City College of New YorkVerified email at ccny.cuny.edu
- Diana C SordilloDepartment of MathematicsVerified email at vanderbilt.edu
- Emilia Mia Sordillo, MD, PhDAssociate Professor, Pathology, Molecular & Cell Based Medicine, Icahn School of Medicine at MountVerified email at mountsinai.org
- Lingyan Shi, PhDUniversity of California San DiegoVerified email at ucsd.edu
- Yang PuDaVinci Applied Technologies Inc.Verified email at sci.ccny.cuny.edu
- Greil-rProfessor of Medicine, Paracelsus Medical University SalzburgVerified email at salk.at
- W. B. WangInstitute for Ultrafast Spectropscopy and Lasers, City College of New YorkVerified email at sci.ccny.cuny.edu
- Cheng-hui Liuthe City College of New YorkVerified email at sci.ccny.cuny.edu
- Susie Boydston-WhiteProfessor of Science, Research ScientistVerified email at bmcc.cuny.edu
- Adler PerotteAssistant Professor, Columbia UniversityVerified email at columbia.edu
- Vidyasagar SriramojuThe City College of New Yor, City University of New YorkVerified email at ccny.cuny.edu
- Gene R DiRestaIndustry ProfVerified email at nyu.edu
- Giovanni MilioneNEC Laboratories America, Inc.Verified email at nec-labs.com
- Samuel AchilefuUniversity of Texas Southwestern Medical Center, DallasVerified email at UTSouthwestern.edu
- Kexian LiangWashington University in St. LouisVerified email at mir.wustl.edu
- Philippe LeprouxAssociate professor in Physics & ICT, University of LimogesVerified email at unilim.fr
Follow
Peter P. Sordillo, A.B., M.D., M.A., M.Phil, PhD, M.S.
Vice-President and Chief Scientific Officer, SignPath Pharma, Inc.
Verified email at nyu.edu